Ishita Drugs and Industries Limited (BOM:524400)
70.00
0.00 (0.00%)
At close: Jan 22, 2026
BOM:524400 Revenue
Ishita Drugs and Industries had revenue of 30.68M INR in the quarter ending September 30, 2025, a decrease of -6.29%. This brings the company's revenue in the last twelve months to 171.64M, up 22.53% year-over-year. In the fiscal year ending March 31, 2025, Ishita Drugs and Industries had annual revenue of 149.97M, down -1.25%.
Revenue (ttm)
171.64M
Revenue Growth
+22.53%
P/S Ratio
1.22
Revenue / Employee
12.26M
Employees
14
Market Cap
209.32M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 149.97M | -1.90M | -1.25% |
| Mar 31, 2024 | 151.88M | 31.15M | 25.81% |
| Mar 31, 2023 | 120.72M | -20.18M | -14.32% |
| Mar 31, 2022 | 140.90M | 1.41M | 1.01% |
| Mar 31, 2021 | 139.49M | -8.83M | -5.95% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Supha Pharmachem | 5.27B |
| Resonance Specialties | 852.48M |
| Tyche Industries | 570.25M |
| Vasundhara Rasayans | 329.60M |
| Krebs Biochemicals & Industries | 272.16M |
| Link Pharma Chem | 258.97M |
| Crestchem | 242.52M |
| Auro Laboratories | 221.88M |